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William Allan Award Address:
On the Role and Soul of a Statistical Geneticist
Ju¨rg Ott1,2,*The Allan Award is truly the culmination of my long career
in human genetics. I am grateful to the American Society
of Human Genetics and to the award committee for
bestowing this honor on me, with previous recipients
including such well-known scientists as Newton Morton,
Arno Motulsky, and Robert Elston. It also feels good to be
among my many friends in human genetics and to cele-
brate this award with them.
In this brief outline of my career, I would like to begin
with my student years and then highlight major results
in my research (the ‘‘role’’ part), concluding with my
current work in China and some thoughts on genetic
versus environmental determinants of disease. In addition
to discussing research work, I will point out the impor-
tance of good mentoring (the ‘‘soul’’ part). When I entered
the University of Zu¨rich at the age of 20, I was unsure what
to study. I always liked mathematics but also many other
things, including playing piano in a jazz band. Eventually,
I decided on zoology as I wanted to know more about
‘‘life.’’ After several years of field work on the cytogenetics
of the common shrew, finishing up with my PhD degree,1
I entered the scientific computing center of a pharmaceu-
tical company in Basel, J.R. Geigy, now Novartis. However,
I was not satisfied with applying statistical tests like recipes
from a cookbook and went to the University of Washing-
ton to embark on an MS program in biomathematics
designed for graduates holding a higher degree. Upon
completion of myMS degree with a thesis on classification1Institute of Psychology, Chinese Academy of Sciences, Beijing 100029, Chin
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planned, I stayed on at the UWas a postdoc in ArnoMotul-
sky’s Division of Medical Genetics.Linkage Analysis
My first task was to develop an approach for genetic
linkage analysis in large family pedigrees. Researchers
around Dr. Motulsky, including Dr. Joseph Goldstein,
had collected a multigenerational kindred, the Alaska
pedigree, segregating familial hypercholesterolemia and
had shown convincing evidence for a monogenic mode
of inheritance.3 However, despite various attempts,
nobody had been able to find evidence for linkage to any
of the several dozen markers then known. Fortunately,
the Elston-Stewart algorithm had just been published
showing how to calculate likelihoods for genetic loci in
large pedigrees,4 and Dr. Joseph Felsenstein pointed out
to me that this could be the basis for a linkage program.
A year of planning and programming in Fortran IV later,
the LIPED program was born.5 I am proud to say that
it contained only one minor error, which was caught by
Dr. Robert Elston: the denominator in the normal density
for quantitative traits was off by a factor of two.
Application of the LIPED program to the Alaska pedigree
demonstrated weak evidence for linkage to the C3 poly-
morphism,6 which was later confirmed independently.7,8
The gene responsible for this form of hypercholesterolemia
turned out to be the LDL receptor; in 1985 Drs. Joseph
Goldstein and Michael Brown received the Nobel prize
for their research on the LDL receptor.
The LIPED program proved to be an instant success
because it was the only freely available software for
linkage analysis in large pedigrees. LIPED formed the basis
for many successful linkage analyses of well-known
traits9–12 and was used as late as 1995,13 20 years after its
publication.
I owe much of my early success to Joseph Felsenstein for
the many discussions we had on the historical background
of statistical genetics. Also, Arno Motulsky was an excel-
lent mentor. Early on he sent me to meetings and gave
me much freedom to pursue my interests. He also allowed
me to hire a programmer, Bob Cottingham, who contrib-
uted much to our work in Seattle and later in Paris.14 It
was partly because of my experience with Arno Motulskya; 2The Rockefeller University, New York, New York 10065, USA
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that I have a strong desire to give to my own students what
I had received so graciously myself. Much later, I was inter-
viewed on my experiences with mentors and on my own
role as a mentor. Several such interviews were incorporated
in a book on mentoring,15 in which Arno Motulsky is
broadly featured as a model mentor.
Zu¨rich City Statistics Office
In the late 1970s, linkage analysis appeared to be losing
some of its importance due to the upcoming methods of
radiation hybrid mapping. For this and personal reasons,
in 1979 I accepted a civil service position as the associate
director of the Statistisches Amt der Stadt Zu¨rich. Although
this must have been a dream job for many people, I sorely
missed science. Fortunately, I had enough free time to
collaborate with science colleagues and to write the first
edition of my textbook.16
A collaboration with colleagues at the University of Basel
involved two sets of families, 194 families previously
collected for screening for CF mutations and genetic coun-
seling, and 1005 families with HLA typing for bone
marrow transplantation. We used this dataset to estimate
the rate of nonpaternity in these families, which posed
interesting statistical problems.17 In the 1607 children
investigated, the observed exclusion rate turned out to be
0.7%, considerably lower than in many other countries18
and evidently lower than in previous centuries.19 The
underlying, true nonpaternity rate in Switzerland was esti-
mated as 0.8%.
Colleagues urged me to extend the LIPED program to
multi-point analysis, but I knew of such efforts being
undertaken by Dr. Mark Lathrop, although he was at the
time only planning to develop a program for marker loci
without regard to disease traits. I convinced him to develop
a general linkage program, and this resulted in the
LINKAGE suite of programs20,21 still in use today. I fondly
remember many weekends in Paris collaborating and
discussing with Drs. Lathrop, Jean-Marc Lalouel, Florence
Demenais, and Jayanti Chotai.22
Transition to Association Analysis
After I started working at Columbia University in 1986,
Joseph Terwilliger became my first student. We carried
out much fruitful work together. One of the highlights
was the development of the haplotype-based haplotype
relative risk (HRR) approach,23 an extension of the HRR
method that had introduced family-based controls as
opposed to population controls.24 Our extension was
based on my theoretical analysis25 showing that the HRR
statistic is different from its null value only in the presence
of linkage (recombination fraction less than 50%) and asso-
ciation (linkage disequilibrium different from zero). This
analysis was also the basis for the TDT, introduced 1993
by Spielman, McGinnis, and Ewens.26 While the TDT is
a test for linkage in the presence of association, a more
general approach is to combine linkage and association
analysis for increased power; our analysis of intervertebralThe Ameridisc disease27 may be viewed as a forerunner of more
modern forms of combined linkage and association
analysis.28
In analyses involving relatives, stated relationships
sometimes have to be taken with a grain of salt; for
example, stated siblings may in reality be half-sibs.
One of my Columbia students, Harald Goring, developed
an approach to estimate relationships from genetic
marker data29 and implemented it in a computer program,
RELATIVE.
Early on, I [was] interested in the question of how to
handle genotyping errors. In my Columbia time, I
proposed ways to incorporate error rates into linkage anal-
ysis by allowing for small probabilities that observed
(apparent) genotypes are different from underlying (true)
genotypes.30 Several years later, regenotyping of a small
number of marker loci allowed us to estimate error rates
and to demonstrate dramatic effects of removing erro-
neous genotypes:31 LOD scores tend to increase, and
map distances (recombination rates) between loci will
become smaller.32
After my move to Rockefeller University in 1996, I
continued investigating effects of errors, now more with
respect to association analysis and family-based associa-
tion analysis. An important observation was that random
errors inflate the type 1 error (rate of false positive results)
of the TDT,33 while as is well-known, errors in linkage anal-
ysis reduce power but do not increase the type 1 error. In
the TDT, this bias is particularly disturbing because with
SNP data, only roughly one-third of errors can be detected
as Mendelian inconsistencies in trio families.34 This work,
spearheaded by Derek Gordon, culminated in the develop-
ment of a very general kind of TDT, TDTae,35 and in its
implementation in a computer program. It estimates error
probabilities based on one of several error models and
treats these estimates as nuisance parameters in a like-
lihood ratio test.
Another focal point of our work has been to investigate
methods assessing the simultaneous disease association of
multiple SNPs. There are two aspects to this task: (1) to
select a set of SNPs and then (2) to assess their association
with disease. One of the first papers to propose a two-
stage procedure incorporating these two steps36 used a
computer-based nested bootstrap technique.37,38 Unfortu-
nately, it did not receive the attention it deserved. Our
development of sum statistics, however, proved to be
very fruitful. Briefly, we select a number m of SNPs (for
example,m¼ 20) based on a given single-locus test statistic
like the chi-square allele test with 1 df. Then, SNPs are
ordered based on the sizes of their test statistics, and
successive sums of the SNP-based test statistics are formed;
for example, the third sum refers to the sum of the three
largest test statistics for three SNPs wherever they occur
in the genome. The significance level associated with
each sum is assessed in randomization samples (labels
case and control are randomly permuted); such a sum is
an approximation to a multivariate test statistic.39 Thecan Journal of Human Genetics 88, 264–268, March 11, 2011 265
Table 1. Potentially Modifiable Risk Factors for Myocardial
Infarction
Risk Factor Odds ratio
Smoking 2.59
Diabetes 3.08
Hypertension 2.48
Abdominal obesity 1.75
Psychosocial 2.51
Exercise 0.72
Alcohol intake 0.79
ApoB/ApoA1 2.36
Based on Yusuf et al.65 but modified and simplified.smallest among allm p values is then taken as our genome-
wide test statistic, whose significance level is estimated
based on the randomization samples already generated.40
This approach has independently been shown to be
more powerful than SNP-by-SNP analysis41–44 and has
been used successfully in various investigations.45–50
Requiring that SNPs be contiguous, sum statistics leads to
what is known as scan statistics, which may be viewed as
genotype-based analogs to haplotype analysis.51 Scan
statistics are ideally suited to investigate, for example,
long stretches of homozygosity in an unbiased manner.52
Last, but not least, I should mention Josephine Hoh’s
investigation of age-related macular degeneration (AMD),
the first chip-based genome-wide association analysis.
Against all odds, it resulted in a spectacular success.53,54
Working in China
In a book recently published on the internet (see Web
Resources), one of the chapters is highly critical of Chinese
universities and other institutions of higher learning and
points out that they ‘‘are in dire need of fundamental
reform, a fact that has been emphasized by China’s polit-
ical and cultural leaders, from Premier Wen Jiabao to the
nationally-revered and recently deceased scientist Qian
Xuesen, both of whom have been sharply critical of the
system’s emphasis on rote learning and intellectual unifor-
mity, at the expense of creativity, innovation, and
discovery.’’ Similar views have recently been expressed by
two leading researchers in Beijing who wrote that ‘‘to
obtain major grants in China, it is an open secret that
doing good research is not as important as schmoozing
with powerful beaurocrats and their favorite reviewers’’55.
The most satisfying and fruitful aspect of my work in
Beijing has been working with my graduate students and
undergraduate summer interns. We have carried out
several interesting pieces of research, for example, esti-
mating whether genotype pattern (diplotype) frequencies
are different in cases and controls,56 and other methods
developments57,58 and data analyses.50,59,60 To support
a healthy development of science research in China, it
seems most promising to pin our hopes on current and
upcoming students and to be good role models for them.
Genetics and Environment
There are well-known examples of traits that are almost
entirely due to environment and others that are mostly
genetically determined. For common complex traits, envi-
ronmental effects are often much stronger than genetic
effects. For example, an ‘‘important [genetic] determinant
of obesity’’ has a pooled odds ratio of 1.2,61 while low
education as a risk factor has an odds ratio of 3.8.62 Also,
the strong association between the APOE gene and
Alzheimer Disease (AD) is well known, but individuals
who eat fish at least once a week have a 60% lower risk
for developing AD.63 It has been noted that approximately
80% of coronary heart disease and 90% of type 2 diabetes
are potentially preventable by life-style modifications.64266 The American Journal of Human Genetics 88, 264–268, March 1One might say that genetic research is likely to uncover
additional genetic risk factors that are not yet known.
However, in a large international study with approxi-
mately 15,000 cases and controls each, potentially
preventable risk factors for heart disease were evaluated.65
It was estimated that 90% of all heart disease cases (popu-
lation attributable risk) are due to one or more of the risk
factors listed in Table 1; clearly, there is not much room
for genetic effects, although some of the risk factors in
Table 1 have a genetic component. It must have been for
these and similar reasons that a proposal was made to
base funding of genetics research on its potential impact
on public health.66 While I cherish genetic research and
would not want to miss it, we should not forget that to
really have an impact on public health, one needs to pref-
erentially act on nongenetic determinants of disease.Acknowledgments
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